Healthcare provider profile · identity verified

John Lank, MD

Internal Medicine · LAKE STEVENS, WA · NPI 1942275797

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	657	210
Amlodipine Besylate	Amlodipine Besylate	521	156
Lisinopril	Lisinopril	435	137
Losartan Potassium	Losartan Potassium	362	112
Omeprazole	Omeprazole	329	99
Levothyroxine Sodium	Levothyroxine Sodium	303	88
Tamsulosin Hcl	Tamsulosin Hcl	217	75
Metoprolol Succinate	Metoprolol Succinate	200	67
Rosuvastatin Calcium	Rosuvastatin Calcium	191	66
Gabapentin	Gabapentin	189	57
Duloxetine Hcl	Duloxetine Hcl	186	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	37
Atenolol	Atenolol	161	49
Tizanidine Hcl	Tizanidine Hcl	160	58
Metformin Hcl Er	Metformin Hcl	149	57
Trazodone Hcl	Trazodone Hcl	149	59
Albuterol Sulfate Hfa	Albuterol Sulfate	148	72
Pantoprazole Sodium	Pantoprazole Sodium	141	46
Simvastatin	Simvastatin	141	38
Hydrochlorothiazide	Hydrochlorothiazide	138	43
Allopurinol	Allopurinol	133	38
Metformin Hcl	Metformin Hcl	130	44
Glipizide Er	Glipizide	113	35
Furosemide	Furosemide	112	39
Tramadol Hcl	Tramadol Hcl	112	19
Jardiance	Empagliflozin	109	38
Potassium Chloride	Potassium Chloride	106	39
Ozempic	Semaglutide	97	23
Citalopram Hbr	Citalopram Hydrobromide	95	22
Alprazolam	Alprazolam	93	24
Prednisone	Prednisone	88	68
Sertraline Hcl	Sertraline Hcl	87	25
Oxycodone Hcl	Oxycodone Hcl	85	13
Fluticasone Propionate	Fluticasone Propionate	75	26
Bupropion Xl	Bupropion Hcl	72	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	72	24
Famotidine	Famotidine	68	16
Diclofenac Sodium	Diclofenac Sodium	67	29
Spironolactone	Spironolactone	65	24
Pregabalin	Pregabalin	64	18
Lovastatin	Lovastatin	62	19
Mirtazapine	Mirtazapine	62	18
Zolpidem Tartrate	Zolpidem Tartrate	61	15
Escitalopram Oxalate	Escitalopram Oxalate	60	17
Ezetimibe	Ezetimibe	57	21
Meloxicam	Meloxicam	56	14
Bupropion Hcl Sr	Bupropion Hcl	54	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	11
Aripiprazole	Aripiprazole	49	suppressed
Finasteride	Finasteride	48	18
Lorazepam	Lorazepam	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	17
Clopidogrel	Clopidogrel Bisulfate	44	13
Fluoxetine Hcl	Fluoxetine Hcl	42	11
Clonazepam	Clonazepam	40	suppressed
Methocarbamol	Methocarbamol	40	17
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	14
Pravastatin Sodium	Pravastatin Sodium	39	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	35
Eliquis	Apixaban	38	15
Propranolol Hcl	Propranolol Hcl	38	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	26
Doxycycline Hyclate	Doxycycline Hyclate	34	16
Nitroglycerin	Nitroglycerin	33	24
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	31	12
Carvedilol	Carvedilol	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	19
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Azithromycin	Azithromycin	30	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Baclofen	Baclofen	27	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	26	18
Telmisartan	Telmisartan	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Loperamide	Loperamide Hcl	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Estradiol	Estradiol	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Ketoconazole	Ketoconazole	24	11
Rabeprazole Sodium	Rabeprazole Sodium	24	suppressed
Valsartan	Valsartan	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Mounjaro	Tirzepatide	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Diazepam	Diazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lactulose	Lactulose	17	suppressed
Risperidone	Risperidone	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Testosterone	Testosterone	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Colchicine	Colchicine	14	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Topiramate	Topiramate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Cephalexin	Cephalexin	12	11
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error